Efficacy of aphrodisiac plants towards improvement in semen quality and motility in infertile males.

Dhanaji Nana Mahavidyalaya, Faizpur.
Journal of Complementary and Integrative Medicine 01/2012; 9(1):Article 6. DOI: 10.1515/1553-3840.1520
Source: PubMed

ABSTRACT Infertility is the inability to conceive after one year of unprotected intercourse. In the present study, herbal composition prepared by using medicinal plants having aphrodisiac potentials was administered orally to the albino rats for 40 days and to the oligospermic patients for 90 days in order to prove the efficacy of herbal composition. Herbal composition was the mixture (powder form) of the medicinal plants namely, Mucuna pruriens (Linn), Chlorophytum borivillianum (Sant and Fernand), and Eulophia campestris (Wall). In the neem oil treated albino rats, there was significant reduction in almost all the parameters viz. body weight, testes and epididymes weight, sperm density and motility, serum levels of testosterone, FSH, and LH compared with control rats. Treatment with said herbal composition for 40 days results significant increased in the body weight, testis, and epididymes weight in rats. Concomitantly the sperm motility and the sperm density were significantly increased. After 90 days of treatment with this herbal composition, sperm density vis-a-vis motility was increased in oligozoospermic patients as a result of elevation in serum testosterone levels. No side effects were noticed during the entire duration of the trial.

  • Source
    Journal of medicinal plant research 01/2012; 6(33):4825-4831. DOI:10.5897/JMPR12.916 · 0.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Safed musli (Chlorophytum borivilianum) is an eminent medicinal plant of India and considered as a 'white gold' or 'divya aushad' in Indian systems of medicine. In Ayurveda, C. borivilianum belongs to the group of "Vajikaran Rasayana' corroborated to its rejuvenating, aphrodisiac, natural sex tonic properties and effective in alleviating sexual disorders. It is largely used as ethnic medicine by local healers of indigenous communities of India. A thorough bibliographic investigation was carried out by analyzing worldwide accepted scientific data base (Pub Med, SciFinder, Scopus and Web of Science), thesis, recognized books, non impact and non indexed journals. Traditionally, C. borivilianum is well known for treating male impotency in India. The multi therapeutic and nutritional importance of C. borivilianum is attributed to the rich source of phytochemicals particularly saponins. Recently, C. borivilianum has gained well established domestic (Indian) and international market for being herbal alternative of "Viagra" without any side effects. Under the trade name 'Nai Chetna', the state government of Gujrat, India, has launched a novel potency drug from C. borivilianum. Modern pharmacological studies of C. borivilianum have demonstrated a wide range of pharmacological activities, most importantly aphrodisiac, immunomodulatory and anticancer activities. The increased commercial exploitation of C. borivilianum and low productivity of this endangered plant has raised the concern over its conservation. It has been envisaged that efforts should be made to standardize, encourage and popularize the cultivation of C. borivilianum as a commercial crop. The analysis of previous pharmacological investigations suggested lack of substantial scientific evidences in various studies and do not stand the test of critical assessment. Due to high economic value, C. borivilianum has also encountered a problem of adulteration with closely resembling medicinally inferior species. The studies available on toxicity, safety and quality of C. borivilianum are inadequate for providing information on commercial utilization. Thus, the present review summarizes comprehensive information on C. borivilianum and possible scope for future research to fill the existing lacunae on its different aspects of the study.
    Journal of ethnopharmacology 09/2013; 150(2). DOI:10.1016/j.jep.2013.08.064 · 2.94 Impact Factor
  • Source
    Antioxidant-Antidiabetic Agents and Human Health, Edited by Oluwafemi Oguntibeju, 02/2014: pages 279-295; InTech., ISBN: 978-953-51-1215-0